Skip to content
OpenCapital
Get started

Nature's Sunshine Products NATR Cardiovascular — Net Sales

Other product segments

General health
$49.07M+6.9%
Digestive
$32.5M+18.0%
Immunity
$10.15M-1.3%
Personal care
$6.98M+53.4%
Weight management
$3.86M-13.4%

Similar metrics at other companies

Boston Scientific logo
BSXCardiovascular — Net Sales
$3.5B+13.5%
Medtronic logo
MDTCardiovascular — Net Sales
$3.8B+13.8%
Boston Scientific logo
BSXCardiovascular — Net sales of reportable segments
$3.5B+10.9%
ITG
ITGRCardio & Vascular — Total sales
$261.73M+1.1%
Organon logo
OGNOther Cardiovascular — Revenue
$28M-6.7%
Clorox logo
CLXHealth and Wellness — Net Sales
$629M-0.2%

Other financials

Income statement

See full
Revenue$122.9M+8.5%
Gross profit$90.0M+10.3%
Operating income$9.5M+54.7%
Net income$5.1M+7.8%
EPS (diluted)$0.29+16.0%

Balance sheet

See full
Cash & equivalents$87.6M+1.3%
Total debt$22.4M+51.1%
Total equity$166.9M-0.1%
Total assets$261.5M+3.5%

Cash flow

See full
Operating cash flow-$1.8M-171%
CapEx$2.5M+123%
Free cash flow-$4.3M-389%

Valuation

See full
Market cap$363.48M+34.2%
Enterprise value$298.33M+49.8%
P/E18.3×-7.7×
P/S0.7×+0.1×

Profitability

See full
Gross margin72.7%+1.0pp
Operating margin5.7%+1.0pp
Net margin4.1%+1.8pp
FCF margin4.7%+0.9pp

Returns & leverage

See full
Return on equity11.9%+5.5pp
Debt / equity0.1×0.0×
Current ratio2.5×+0.1×

Where this comes from

Reported directly by Nature's Sunshine Products in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Nature's Sunshine Products’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nature's Sunshine Products's cardiovascular — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nature's Sunshine Products's cardiovascular — net sales?
Nature's Sunshine Products (NATR) reported cardiovascular — net sales of $20.34M in Q1 2026.
How has Nature's Sunshine Products's cardiovascular — net sales changed year-over-year?
Nature's Sunshine Products's cardiovascular — net sales decreased by 0.8% year-over-year, from $20.51M to $20.34M.
What is the long-term trend for Nature's Sunshine Products's cardiovascular — net sales?
Over 4 years (2021 to 2025), Nature's Sunshine Products's cardiovascular — net sales has grown at a 1.1% compound annual growth rate (CAGR), from $78.03M to $81.64M.
What does cardiovascular — net sales mean?
This metric represents the total revenue generated from the sale of nutritional and wellness products specifically formulated to support cardiovascular health. It reflects the market demand and consumer adoption of the company's heart-health product portfolio within its broader wellness offerings. Tracking this figure helps investors assess the performance and growth trajectory of a key product category within the company's health and wellness segment.